Global Dural Arteriovenous Fistulas Treatment Market to Observe Strong Development by 2023

Dural Arteriovenous Fistulas Treatment Market -Highlights
Dural Arteriovenous Fistula is an abnormal connection between an artery and a vein. Any organ of the body can suffer from fistula. The brain is bounded by a tough fibrous cover called dura mater or dura. When a fistula forms between an artery and a vein within the dura, it is called brain dural fistula.
The global Dural Arteriovenous Fistulae Treatment Market is expected to grow at a CAGR of 7.68% during the forecast period 2017-2023.
According to Migraine Research Foundation, migraine was the 3rd most prevalent illness in the world in 2014. The prevalence of migraine is very high in the US, which is nearly 1 in 4 people. Moreover, 18% of American women, 6% of men, and 10% of children experience migraines. Mostly migraine occurs at the age of 25-55.
Increasing prevalence of neurological disorder such as epilepsy and migraine leads to Dural arteriovenous fistulae, and increasing investment in biotechnology and pharmaceutical industries in R&D drive the growth of the market.
Dural Arteriovenous Fistulas Treatment Market -Key Players
  • BD (U.S.)
  • Medtronic (U.S.)
  • B. Braun Melsungen AG (Germany)
  • Cook (U.S.)
  • Teleflex Incorporated (U.S.)
  • Fresenius Medical Care AG & Co. KGaA (Germany)
  • NxStage Medical, Inc. (U.S.)
  • Poly Medicure Limited
Dural Arteriovenous Fistulas Treatment Market -Segmentation
·         The global dural arteriovenous fistulae treatment market is segmented on the basis of type, treatment, and end user.
·         On the basis of type, the market is segmented into type I, type II, and type III.
·         On the basis of application, the market is segmented into surgery, stereotactic radiosurgery, embolization, and others.
·         On the basis of end user, the market is segmented into hospitals & clinics, ambulatory surgical centers, and others.
Dural Arteriovenous Fistulas Treatment Market -Regional Analysis
The Americas dominates the global Dural arteriovenous fistulae treatment market owing to the presence of huge patient population with brain injury and neurological disorder such as depression, epilepsy, and migraine, high healthcare spending, and increasing government support for research & development.
Europe holds the second largest share of the global Dural arteriovenous fistulae treatment market. Market. Asia Pacific is the fastest growing Dural arteriovenous fistulae treatment market across the globe. 

Comments

Post a Comment

Popular posts from this blog

Proteomics Market Analysis, Demand Overview, Growth Analysis, Current Trends, Updates, and Global Industry Forecast to 2023

Market Highlights: The global proteomics market is anticipated to hold a market value of USD 23.2 billion in the year 2017 and is expected to grow at a CAGR of 14.1% during the forecast period. Proteomics is a science which is used to estimate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Also, it has extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis. Increasing need for personalized medicine, R&D expenditure, technological advancements and increased funding for proteomics project are expected to drive the market growth over the forecast period. For instance, in July 2017, Biognosys AG received USD 5 million funding from its new as well as existing investors. These new funds will be used for extending commercial operations and also to accelerate the development of next generation prote...
Read more

Pancreatic Cancer Market: America to Command the Largest Share

Market Overview: Pancreatic cancer can be defined as an enlarged tumor, which is generally caused by malignant cells present in the tissues of the pancreas. This type of cancer is generally caused due to drinking alcohol, smoking, genetic factors, radiotherapy in the past, obesity, inflammation of the pancreas, and diabetes mellitus. It is a type of cancer that starts in the pancreas and is a highly lethal disease. The global Pancreatic Cancer Market , as per a report by Market Research Future (MRFR) is touted to register 8.1% CAGR during the forecast period ( 2017-2023 ). The dearth of therapeutic approaches for early-stage detection has resulted in increased incidences of pancreatic cancer. Soaring prevalence of pancreatic cancer has resulted in germline mutations, thereby causing the defective genes to pass down to the children from their parents, thus making early detection of pancreatic cancer important. This has led to the growth of the market across the globe. Surging dem...
Read more

Immune Thrombocytopenia (ITP) Market is Estimated to Record Promising CAGR of 5.78% During Forecast 2018-2023

Market Highlights: As per the latest report published by Market Research Future (MRFR), the Global Immune Thrombocytopenia (ITP) is set to surpass a valuation of USD 2,300 Mn by the year 2023, reflecting a healthy CAGR. ITP is a blood related disorder that cause abnormal clotting. Some of the discomforts caused by the disease include bruising, bleeding and severe drop in platelets counts. Both minors and adults can develop the condition. The disease is classified into primary and secondary form. Primary form of ITP occurs on its own while the latter is an offshoot of another condition. The condition can be triggered by reactive medications, autoimmune disease, pregnancy and certain type of cancers. ITP is among the most commonly occurring disorder across the globe. In addition, the incidence rate has continued to spiral upwards in recent years. Factors as such as are fueling the demand for drugs and therapeutics for ITP. Currently, there are four treatment options available for ...
Read more